2 news items
MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development Update
MNKD
8 May 24
, partially offset by reduced personnel costs. Interest income, net, was $3.4 million for the first quarter of 2024 compared to $1.3
MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
MNKD
27 Feb 24
which commenced in the second quarter of 2023, INHALE-1 and other research and development activities, partially offset by a decrease in development
- Prev
- 1
- Next